Real-time PCR-based assays designed to simultaneously detect multiple pathogens across respiratory, gastrointestinal, sexually transmitted infection, and HPV categories. These multiplex panels enable comprehensive pathogen identification in a single test for improved diagnostic efficiency.
Manufactured by
SeeGene Middle East FZE
South Korea
Seegene is a South Korean biotechnology company founded in 2000, specializes in the development, manufacturing, and global distribution of molecular diagnostic (MDx) products, especially in vitro diagnostics (IVD) based on PCR technology. Currently, our product portfolio consists of over 250 molecular diagnostic assays.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
SpeeDx Pty Ltd
United States · 4 relevant products
Lusis Biosciences Inc
United States · 5 relevant products
Molecular Designs
United States · 6 relevant products
47 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →11 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 97 closest product alternatives
SpeeDx Pty Ltd · United States
Multiplexed solutions identifying key pathogens for infectious disease research. These assays provide flexible solutions detecting bacteria, viruses, and parasites contributing to gastrointestinal illness, panels for detection of common fungi causing dermatophytosis, and expanded target selection for STIs, respiratory, or lesion applications.
Lusis Biosciences Inc · United States
Multiplexed molecular assays for detection of sexually transmitted pathogens using qPCR methodology. Enables concurrent detection of multiple STI targets from patient specimens.
Lusis Biosciences Inc · United States
qPCR-based diagnostic assays for detection of sexually transmitted pathogens with multiplexing capabilities. Provides simultaneous identification of multiple targets in single reactions.
94 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products